EUVIMEDEUVIMED entdecken
Open Access

Increased palmitoylation improves estrogen receptor alpha–dependent hippocampal synaptic deficits in a mouse model of synucleinopathy

Tim E Moors iD, Shaomin Li iD, Thomas D McCaffery iD, Gary P H Ho iD, Pascal A Bechade, Luu N Pham iD, Maria Ericsson iD, Silke Nuber

Science Advances · 17.11.2023 · 9 (46)

DOI: 10.1126/sciadv.adj1454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 17.11.2023. Verfasst von Tim E Moors und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is characterized by conversion of soluble α-synuclein (αS) into intraneuronal aggregates and degeneration of neurons and neuronal processes. Indications that women with early-stage PD display milder neurodegenerative features suggest that female sex partially protects against αS pathology. We previously reported that female sex and estradiol improved αS homeostasis and PD-like phenotypes in E46K-amplified (3K) αS mice. Here, we aimed to further dissect mechanisms that drive this sex dimorphism early in disease. We observed that synaptic abnormalities were delayed in females and improved by estradiol, mediated by local estrogen receptor alpha (ERα). Aberrant ERα distribution in 3K compared to wild-type mice was paired with its decreased palmitoylation. Treatment with ML348, a de-palmitoylation inhibitor, increased ERα availability and soluble αS homeostasis, ameliorating synaptic plasticity and cognitive and motor phenotypes. Our finding that sex differences in early-disease αS–induced synaptic impairment in 3KL mice are in part mediated by palmitoylated ERα may have functional and pathogenic implications for clinical PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseSynucleinopathiesAnimalsFemaleHumansMaleMiceDisease Models, AnimalEstradiolEstrogen Receptor alphaHippocampusLipoylationMice, Transgenic

Substanzen

EstradiolEstrogen Receptor alphaEsr1 protein, mouse

Autor:innen und Institutionen

  • Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Laboratory for Drug Discovery in Neurodegeneration, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Electron Microscopy Laboratory, Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Tim E Moors, Shaomin Li, Thomas D McCaffery, Gary P H Ho, Luu N Pham, Maria Ericsson

Förderung

  • NINDS NIH HHS

Zitieren

APA

Moors, T. E., Li, S., McCaffery, T. D., Ho, G. P. H., Bechade, P. A., Pham, L. N., Ericsson, M., & Nuber, S. (2023). Increased palmitoylation improves estrogen receptor alpha–dependent hippocampal synaptic deficits in a mouse model of synucleinopathy. Science Advances, 9(46). https://doi.org/10.1126/sciadv.adj1454

Vancouver

Moors TE, Li S, McCaffery TD, Ho GPH, Bechade PA, Pham LN, et al. Increased palmitoylation improves estrogen receptor alpha–dependent hippocampal synaptic deficits in a mouse model of synucleinopathy. Science Advances. 2023;9(46). doi:10.1126/sciadv.adj1454

BibTeX
@article{Moors2023,
  author = {Moors, Tim E and Li, Shaomin and McCaffery, Thomas D and Ho, Gary P H and Bechade, Pascal A and Pham, Luu N and Ericsson, Maria and Nuber, Silke},
  title = {Increased palmitoylation improves estrogen receptor alpha–dependent hippocampal synaptic deficits in a mouse model of synucleinopathy},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {46},
  doi = {10.1126/sciadv.adj1454}
}
Kostenlos starten →